The Effects of Trimetazidine on QT-interval Prolongation and Cardiac Hypertrophy in Diabetic Rats

BACKGROUND: Trimetazidine (TMZ) is an anti-ischemic drug. In spite of its protective effects on cardiovascular system, there is no scientific study on the usefulness of TMZ treatment for prolonged QT interval and cardiac hypertrophy induced by diabetes. OBJECTIVES: To evaluate the effects of TMZ on...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramezani-Aliakbari, Fatemeh, Badavi, Mohammad, Dianat, Mahin, Mard, Seyed Ali, Ahangarpour, Akram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371832/
https://www.ncbi.nlm.nih.gov/pubmed/30570065
http://dx.doi.org/10.5935/abc.20180248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371832/
https://www.ncbi.nlm.nih.gov/pubmed/30570065
http://dx.doi.org/10.5935/abc.20180248

Ejemplares similares